Table 2 Benchmark results (3 repeated runs; mean ± std. dev.) of Fitzpatrick17k-C for all the experiments originally reported by Groh et al.20.
From: Investigating the Quality of DermaMNIST and Fitzpatrick17k Dermatological Image Datasets
Holdout Set | Verified | Random (Stratified) | Source A (Atl. Derm.) | Source B (DermaAmin) | FST 3–6 | FST 1–2 & 5–6 | FST 1–4 |
---|---|---|---|---|---|---|---|
# Train Images | 10,060 | 7,975 | 6,129 | 2,175 | 5,340 | 3,312 | 935 |
# Validation Images | 1,119 | 1,139 | 703 | 220 | 599 | 337 | 122 |
# Test Images | 215 | 2,280 | 2,395 | 6,832 | 5,029 | 6,685 | 6,903 |
Best Hyperparameters (n_epochs, optim, lr) | (200, Adam, 1e-3) | (200, Adam, 1e-4) | (100, Adam, 1e-4) | (200, SGD, 1e-2) | (100, Adam, 1e-4) | (200, Adam, 1e-4) | (200, Adam, 1e-4) |
Overall | 4.65% ± 0.00% | 24.05% ± 0.34% | 16.62% ± 0.86% | 5.16% ± 0.20% | 14.42% ± 0.13% | 17.27% ± 0.38% | 12.07% ± 0.28% |
Type 1 | 3.51% ± 1.24% | 21.71% ± 0.47% | 22.55% ± 0.80% | 4.80% ± 0.38% | — | 15.05% ± 0.35% | 7.85% ± 0.36% |
Type 2 | 6.92% ± 0.89% | 21.06% ± 0.50% | 18.57% ± 0.51% | 4.11% ± 0.38% | — | 16.43% ± 0.40% | 9.81% ± 0.27% |
Type 3 | 0.90% ± 1.27% | 23.72% ± 0.68% | 14.39% ± 1.34% | 5.21% ± 0.42% | 17.18% ± 0.15% | — | 13.23% ± 0.54% |
Type 4 | 8.33% ± 1.18% | 28.56% ± 0.93% | 15.32% ± 0.61% | 6.62% ± 0.52% | 13.16% ± 0.45% | — | 20.22% ± 0.30% |
Type 5 | 1.45% ± 2.05% | 32.09% ± 0.77% | 19.43% ± 1.53% | 8.12% ± 0.90% | 12.23% ± 0.47% | 25.70% ± 0.50% | — |
Type 6 | 4.55% ± 0.00% | 25.97% ± 1.06% | 15.32% ± 2.37% | 8.00% ± 1.08% | 9.29% ± 0.22% | 18.11% ± 0.45% | — |
Groh et al.20: Overall | 26.7% | 20.2% | 27.4% | 11.4% | 13.8% | 13.4% | 7.7% |